{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:52:28Z","timestamp":1774558348284,"version":"3.50.1"},"reference-count":51,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100009898","name":"Defense Health Agency","doi-asserted-by":"publisher","award":["HU00012120025"],"award-info":[{"award-number":["HU00012120025"]}],"id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01AT008404"],"award-info":[{"award-number":["R01AT008404"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH120122"],"award-info":[{"award-number":["R01MH120122"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["PM&amp;R"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Over\u2010prescription of opioids has diminished in recent years; however, certain populations remain at high risk. There is a dearth of research evaluating prescription rates using specific multimorbidity patterns.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To identify distinct clinical profiles associated with opioid prescription and evaluate their relative odds of receiving long\u2010term opioid therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective analysis of the complete military electronic health record. We assessed demographics and 26 physiological, psychological, and pain conditions present during initial opioid prescription. Latent class analysis (LCA) identified unique clinical profiles using diagnostic data. Logistic regression measured the odds of these classes receiving long\u2010term opioid therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>All electronic health data under the TRICARE network.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>All servicemembers on active duty during fiscal years 2016 through 2019 who filled at least one opioid prescription.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>Number and qualitative characteristics of LCA classes; odds ratios (ORs) from logistic regression. We hypothesized that LCA classes characterized by high\u2010risk contraindications would have significantly higher odds of long\u2010term opioid therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of <jats:italic>N<\/jats:italic>\u2009=\u2009714,446 active duty servicemembers were prescribed an opioid during the study window, with 12,940 (1.8%) receiving long\u2010term opioid therapy. LCA identified five classes: Relatively Healthy (82%); Musculoskeletal Acute Pain and Substance Use Disorders (6%); High Pain, Low Mental Health Burden (9%); Low Pain, High Mental Health Burden (2%), and Multisystem Multimorbid (1%). Logistic regression found that, compared to the Relatively Healthy reference, the Multisystem Multimorbid class, characterized by multiple opioid contraindications, had the highest odds of receiving long\u2010term opioid therapy (OR\u2009=\u20099.24; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001; 95% confidence interval [CI]: 8.56, 9.98).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Analyses demonstrated that classes with greater multimorbidity at the time of prescription, particularly co\u2010occurring psychiatric and pain disorders, had higher likelihood of long\u2010term opioid therapy. Overall, this study helps identify patients most at risk for long\u2010term opioid therapy and has implications for health care policy and patient care.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pmrj.12994","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T03:53:36Z","timestamp":1683777216000},"page":"14-24","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic profiles associated with long\u2010term opioid therapy in active duty servicemembers"],"prefix":"10.1002","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-1343","authenticated-orcid":false,"given":"Steven","family":"Dufour","sequence":"first","affiliation":[{"name":"Department of Medical and Clinical Psychology Uniformed Services University of the Health Sciences  Bethesda Maryland USA"},{"name":"Naval Medical Center Portsmouth  Portsmouth Virginia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Banaag","sequence":"additional","affiliation":[{"name":"The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc  Bethesda Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Schoenfeld","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery Brigham and Women's Hospital, Harvard Medical School  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel Sayko","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Health Law, Policy and Management Boston University School of Public Health  Boston Massachusetts USA"},{"name":"Rocky Mountain Mental Illness Research Education and Clinical Center Veterans Health Administration  Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey Perez","family":"Koehlmoos","sequence":"additional","affiliation":[{"name":"Center for Health Services Research Uniformed Services University of the Health Sciences  Bethesda Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua C.","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Medical and Clinical Psychology Uniformed Services University of the Health Sciences  Bethesda Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.09.022"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usz487"},{"key":"e_1_2_10_4_1","unstructured":"Centers for Disease Control and Prevention.US Opioid Dispensing Rate Maps.2021https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxrate\u2010maps.html#:~:text=The%20overall%20national%20opioid%20dispensing%20rate%20declined%20from%202012%20to than%20153%20million%20opioid%20prescription. Published 2021. Updated November 10 Accessed July 25 2022."},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000059"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222674"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/HTR.0000000000000481"},{"key":"e_1_2_10_8_1","unstructured":"Department of Veterans Affairs Department of Defense.VA\/DoD Clinical Practice Guideline for the Use of Opioids in the Management of Chronic Pain.2022."},{"key":"e_1_2_10_9_1","unstructured":"Department of Veterans Affairs Department of Defense.VA\/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain.2017."},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06536-8"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000402"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370805300403"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.16.01075"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.3132"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usab506"},{"key":"e_1_2_10_17_1","unstructured":"AHFS Clinical Drug Information.Bethesda MD.2020."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.2628"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.01.016"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.0480"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usx200"},{"key":"e_1_2_10_22_1","unstructured":"Centers for Disease Control and Prevention.Clinical Guidance for Selected Common Acute Pain Conditions: Current Treatment Recommendations from Professional Organizations.2021https:\/\/www.cdc.gov\/acute-pain\/index.html. Published 2020. Updated March 13 2020. Accessed January 14 2021"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.05.008"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.01.24"},{"key":"e_1_2_10_25_1","unstructured":"DziakJJ LanzaST.Personal communication. November 222021."},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219717"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/10705511.2014.935751"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/88.3.767"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1037\/tps0000176"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/10705510701575396"},{"key":"e_1_2_10_31_1","volume-title":"Confirmatory Factor Analysis for Applied Research","author":"Brown T","year":"2015"},{"key":"e_1_2_10_32_1","unstructured":"SAS Institute Inc.SAS 9.4. In. Cary NC.2013."},{"key":"e_1_2_10_33_1","unstructured":"Department of Defense.Demographics: Profile of the Military Community. militaryonesource.mil2017.2016."},{"key":"e_1_2_10_34_1","unstructured":"Department of Defense.Demographics: Profile of the Military Communitymilitaryonesource.mil2018.2017."},{"key":"e_1_2_10_35_1","unstructured":"Department of Defense.Demographics: Profile of the Military Community. militaryonesource.mil2019.2018."},{"key":"e_1_2_10_36_1","unstructured":"Department of Defense.Demographics: Profile of the Military Community. militaryonesource.mil2020.2019."},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa2034159"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2007.64"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6968"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13741-018-0105-8"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2021-014186"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2021.07.024"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/24740527.2020.1768836"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/20008198.2019.1608717"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.4324\/9781351164047-19"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106743"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.12.010"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.05.033"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1308222"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usaa573"},{"key":"e_1_2_10_51_1","unstructured":"Defense Health Agency.DHA Procedural Instruction 6025.04: Pain Management and Opioid Safety in the Military Health System. June 8 20182018."},{"key":"e_1_2_10_52_1","unstructured":"Defense Health Agency.DHA Procedural Instruction 6025.07: Naloxone Prescribing and Dispensing by Pharmacists in Medical Treatment Facilities(MTFs). June 19 20182018."}],"container-title":["PM&amp;R"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/am-pdf\/10.1002\/pmrj.12994","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pmrj.12994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T14:02:01Z","timestamp":1705672921000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pmrj.12994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1002\/pmrj.12994"],"URL":"https:\/\/doi.org\/10.1002\/pmrj.12994","archive":["Portico"],"relation":{},"ISSN":["1934-1482","1934-1563"],"issn-type":[{"value":"1934-1482","type":"print"},{"value":"1934-1563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"2022-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}